Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.

Biotechnology

Education

Seismic Therapeutic

Jo Viney

Melanie Manning

Yi Xing

Ivan Mascanfroni

Daniela Cipolletta

Jyothsna Visweswaraiah

John Sundy

Kevin Otipoby

Edward Freedman

Maude Tessier

Debora Marks

Nathan Higginson-Scott

The Scientific Research and Development Team at Seismic Therapeutic is responsible for leveraging machine learning to advance biologics drug discovery and development. The team integrates expertise in structural biology, protein engineering, and translational immunology to create optimized therapies for autoimmune diseases. Key activities include conducting innovative scientific research, developing new methodologies, and advancing the company's pipeline of novel biologics from discovery to clinical development.

Scientific Research and Development Team

Leadership Team

Directors and Managers

Scientific Research and Development Team

About

Team members

Other teams at Seismic Therapeutic

Leadership Team

Directors and Managers